- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jupiter Neurosciences Inc (JUNS)
Jupiter Neurosciences Inc stock price live, this page displays NASDAQ JUNS stock exchange data. View the JUNS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jupiter Neurosciences Inc real time stock price chart below.
What Is the Jupiter Neurosciences Inc Stock Price Today?
The Jupiter Neurosciences Inc stock price today is 1.57.
What Is the Stock Symbol for Jupiter Neurosciences Inc?
The stock symbol for Jupiter Neurosciences Inc is "JUNS."
What Stock Exchange Does Jupiter Neurosciences Inc Trade On?
Jupiter Neurosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Jupiter Neurosciences Inc a Good Stock to Buy?
Determining whether Jupiter Neurosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JUNS quote. (ISIN: US48208B2034)
What Is the Jupiter Neurosciences Inc Stock Price Today?
The Jupiter Neurosciences Inc stock price today is 1.57.
What Is the Stock Symbol for Jupiter Neurosciences Inc?
The stock symbol for Jupiter Neurosciences Inc is "JUNS."
What Stock Exchange Does Jupiter Neurosciences Inc Trade On?
Jupiter Neurosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Jupiter Neurosciences Inc a Good Stock to Buy?
Determining whether Jupiter Neurosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JUNS quote. (ISIN: US48208B2034)
NASDAQ
Currency in USD
1.56
+0.09(+6.12%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.43
1.66
52 wk Range
0.51
19.51
JUNS Scorecard
Full Analysis
Significant return over the last week
JUNS is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.431.66
52 wk Range
0.5119.51
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
JUNS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
30.00
Upside
+1,823.08%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Jupiter Neurosciences Inc Company Profile
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products for the treatment of neuroinflammation. The company develops JNS101, which is in Phase II trial for the treatment of Friedreich's Ataxia, a rare inherited disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS108 that is in Phase II trial for treating mild cognitive impairment/early Alzheimer’s disease. It is also involved in the development of JNS102, which is in Phase II trial for the treatment of mucopolysaccharidosis type 1; and JNS107 that is in Phase II trial for treating mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome. In addition, the company develops JNS115, which is in Phase IIa trial for the treatment of Parkinson’s disease. It has a strategic partnership with Zina Biopharmaceuticals, LLC to advance Phase 2a clinical trial to evaluate the safety, tolerability, and pharmacokinetics of Resveratrol (JOTROLTM) in individuals with Parkinson’s disease; and with Aquanova AG to develop a series of consumer-focused nutritional products targeting longevity, aging, and healthspan. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. Jupiter Neurosciences, Inc. was incorporated in 2016 and is headquartered in Jupiter, Florida.
Compare JUNS to Peers and Sector
Metrics to compare | JUNS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJUNSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −16.0x | −0.3x | −0.5x | |
PEG Ratio | −0.69 | 0.00 | 0.00 | |
Price/Book | 17.4x | 0.3x | 2.6x | |
Price / LTM Sales | - | 0.8x | 3.1x | |
Upside (Analyst Target) | - | 155.9% | 47.8% | |
Fair Value Upside | Unlock | 10.5% | 6.9% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 30.00
(+1,823.08% Upside)
Earnings
Latest Release
May 28, 2025
EPS / Forecast
-0.05 / -0.03
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Jupiter Neurosciences (JUNS) Stock Price Today?
The Jupiter Neurosciences stock price today is 1.56
What Stock Exchange Does Jupiter Neurosciences Trade On?
Jupiter Neurosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Jupiter Neurosciences?
The stock symbol for Jupiter Neurosciences is "JUNS."
What Is the Jupiter Neurosciences Market Cap?
As of today, Jupiter Neurosciences market cap is 48.66M.
What Is Jupiter Neurosciences's Earnings Per Share (TTM)?
The Jupiter Neurosciences EPS (TTM) is -0.11.
When Is the Next Jupiter Neurosciences Earnings Date?
Jupiter Neurosciences will release its next earnings report on 02 Sept 2025.
From a Technical Analysis Perspective, Is JUNS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Jupiter Neurosciences Stock Split?
Jupiter Neurosciences has split 0 times.
How Many Employees Does Jupiter Neurosciences Have?
Jupiter Neurosciences has 4 employees.
What is the current trading status of Jupiter Neurosciences (JUNS)?
As of 09 July 2025, Jupiter Neurosciences (JUNS) is trading at a price of 1.56, with a previous close of 1.47. The stock has fluctuated within a day range of 1.43 to 1.66, while its 52-week range spans from 0.51 to 19.51.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.